Sam Wertheimer

Sam P.
Wertheimer is the founder of Poliwogg, Inc., founded in 2012.
Current jobs include Chairman & Executive Vice President at Poliwogg Regenerative Medicine Fund, Inc. since 2014, Chairman at Brookline Capital Acquisition Corp.
II starting in 2025, and Chief Investment Officer, EVP & Managing Director at Poliwogg Advisers LLC since 2014.
Former jobs include Chairman & Chief Executive Officer at Brookline Capital Acquisition Corp., Director at Corus Pharma, Inc. from 2001 to 2006, Director at Salmedix, Inc. from 2004 to 2005, Director at ChemoCentryx, Inc. from 2001 to 2011, Director at Biodel, Inc. from 2006 to 2009, Director at Cerimon Pharmaceuticals, Inc., Director at InteKrin Therapeutics, Inc. from 2007 to 2010, Director-Industrial Liaison at New York University School of Medicine Foundation from 1998 to 2000, Director at NeurAxon, Inc. from 2007 to 2010, Director at Apexigen, Inc. from 2022 to 2023, and Principal at OrbiMed Advisors Private Equity from 2000 to 2011.
Education includes undergraduate degree from The Johns Hopkins University, graduate degree from Yale University, and doctorate from New York University.